Tandem Diabetes Care Launches Remote Software Update for Insulin Pump Through a PC

Tandem Diabetes Care Inc., a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, has released a software update for t:slim Insulin Pumps purchased before April 2015. The software update will be available via personal computer using the Tandem Device Updater, a Mac and PC-compatible tool for the remote deployment of Tandem insulin pump software. This represents the first time an insulin pump manufacturer has provided a software update for customers using their personal computer.
 
“The first-of-its-kind Tandem Device Updater represents an important advancement in the way functionality is delivered to insulin pump users, making it possible to provide new pump features to our customers independent of the typical pump insurance replacement cycle,” said Kim Blickenstaff, president and CEO of Tandem Diabetes Care. “We are working on exciting new software updates to offer our customers as they are approved by the FDA, such as integration with Dexcom’s G5 Mobile CGM system and automated insulin delivery algorithms, and today’s launch is the first step in this direction.”
 
The software update launched today provides the latest t:slim Insulin Pump software to in-warranty t:slim Pumps purchased before April 2015. The features included in this software release began shipping on new t:slim Pumps in April 2015, and include a variety of product enhancements for convenience and flexibility.

In-warranty customers who purchased their t:slim Pump before April 2015 will receive an email in the next three weeks with their unique Update ID Number and instructions on how to update their pump.
 
Consistent with past product development efforts, the design of the Tandem Device Updater was driven significantly by direct input from pump users. Following clearance by the U.S. Food and Drug Administration, Tandem conducted additional customer testing to further refine the user experience. Approximately two thirds of the 300 customers who participated in the beta release completed a survey after their download. Survey results reported that the product was easy to use, with more than 90 percent indicating they would be likely to download future software updates.
 
Tandem Diabetes Care Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The company manufactures and sells the t:slim X2 Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, the t:flex Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4 Insulin Pump, the first continuous glucose monitoring-enabled pump with touchscreen simplicity. Tandem is based in San Diego, Calif.